在医疗保险中,慢性疾病管理计划的初步发现使轻度至中度脏疾病的入学者受益
Trevon Morales1, Rubette Harford2, Dulcie Kermah3
1David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
International journal of environmental research and public health
|February 27, 2026
概括
波多黎各的一项慢性病管理 (CDM) 计划帮助79%患有早期慢性病 (CKD) 的参与者稳定或改善功能. 这项干预针对该地区的高CKD率,显示了对管理脏健康的有希望的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
- 慢性疾病管理 慢性疾病管理
背景情况:
- 与美国大陆相比,波多黎各的慢性病 (CKD) 患病率明显高于美国大陆.
- 糖尿病是CKD的主要风险因素.
- 为了解决这些差异,制定了一项多学科的慢性疾病管理 (CDM) 计划.
研究的目的:
- 对波多黎各的CKD和DM患者进行多学科CDM计划的有效性进行评估.
- 根据随着时间的推移估计的膜过率 (eGFR) 来评估CKD阶段的变化.
主要方法:
- 波多黎各的7200多名医疗保险注册者是CDM计划的目标.
- 4068名患有CKD或DM的参与者通过eGFR确定了他们的CKD阶段.
- 一个专门的团队提供了饮食,生活方式和医疗建议.
主要成果:
- 在2095名患有CKD 1-3阶段的参与者中,79%的CKD状态在随访期间稳定或改善.
- 对665名第三阶段CKD参与者的二次分析显示,与历史对照相比,回归率更高 (20.3%) 和进展率更低 (3.9%).
- 大多数患有第1或第2阶段CKD的参与者保持在他们的阶段或回归.
结论:
- 早期发现表明,多学科CDM干预有效地稳定或改善早期CKD.
- 需要进一步研究随机对照组和更长的随访,以确认因果关系和长期结果.
相关概念视频
01:18Chronic Kidney Disease IV: Nursing Management
476
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
476
01:28Chronic Kidney Disease III: Interprofessional Care
529
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529
01:24Chronic Kidney Disease II: Clinical Manifestations
795
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
795
01:25Chronic Kidney Disease I: Introduction
863
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
863
01:22Acute Kidney Injury VI: Nursing Management
577
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
577
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
282
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
282